Global Human Papillomavirus (HPV) Therapeutics Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	161 Pages	TechNavio	March, 2023	INF17838598

Best Price Guarantee
Price	from $2,500
Length	161 Pages
Publisher	TechNavio
Published Date	March, 2023
SKU	INF17838598

Global Human Papillomavirus (HPV) Therapeutics Market 2023-2027

Technavio has been monitoring the human papillomavirus (HPV) therapeutics market and is forecast to grow by $953.3 mn during 2022-2027, accelerating at a CAGR of 5.15% during the forecast period. Our report on the human papillomavirus (HPV) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advent of vaccines, development of oral vaccines for HPV, and strong disease progression.

Technavio's human papillomavirus (HPV) therapeutics market is segmented as below:

By Route of Administration

Parenteral
Topical

By Indication

Cervical cancer
Anal cancer
Vulvar and vaginal cancer
Others

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the r and d of new drugs for orthostatic hypotension treatment as one of the prime reasons driving the human papillomavirus (HPV) therapeutics market growth during the next few years. Also, use of combination therapy in treatment and the adoption of fludrocortisone as off label first line pharmacotherapy will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the human papillomavirus (HPV) therapeutics market covers the following areas:

Human papillomavirus (HPV) therapeutics market sizing
Human papillomavirus (HPV) therapeutics market forecast
Human papillomavirus (HPV) therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human papillomavirus (HPV) therapeutics market vendors that include 2A Pharma ApS, AbbVie Inc., Bavarian Nordic AS, BioVaxys Technology Corp., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, ISA Pharmaceuticals BV, Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co. Ltd., Xiamen Innovax Biotech Co. Ltd., Merck and Co. Inc., Bausch Health Co. Inc., and Inovio Pharmaceuticals Inc. Also, the human papillomavirus (HPV) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Route of Administration
  - Table Executive Summary – Chart on Market Segmentation by Indication
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Global - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Global - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Historic Market Size
- Global Human Papillomavirus (HPV) therapeutics market 2017 - 2021
  - Table Historic market size – Data table on global Human Papillomavirus (HPV) therapeutics market 2017 - 2021 ($ million)
- Route of administration segment analysis 2017 - 2021
  - Table Historic market size – Route of administration segment 2017 - 2021 ($ million)
- Indication segment analysis 2017 - 2021
  - Table Historic market size – Indication segment 2017 - 2021 ($ million)
- Geography segment analysis 2017 - 2021
  - Table Historic market size – Geography segment 2017 - 2021 ($ million)
- Country segment analysis 2017 - 2021
  - Table Historic market size – Country segment 2017 - 2021 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Route of Administration
- Market segments
  - Table Chart on Route of Administration - Market share 2022-2027 (%)
  - Table Data Table on Route of Administration - Market share 2022-2027 (%)
- Comparison by Route of Administration
  - Table Chart on Comparison by Route of Administration
  - Table Data Table on Comparison by Route of Administration
- Parenteral - Market size and forecast 2022-2027
  - Table Chart on Parenteral - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Parenteral - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Parenteral - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
- Topical - Market size and forecast 2022-2027
  - Table Chart on Topical - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Topical - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Topical - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Topical - Year-over-year growth 2022-2027 (%)
- Market opportunity by Route of Administration
  - Table Market opportunity by Route of Administration ($ million)
  - Table Data Table on Market opportunity by Route of Administration ($ million)
Market Segmentation by Indication
- Market segments
  - Table Chart on Indication - Market share 2022-2027 (%)
  - Table Data Table on Indication - Market share 2022-2027 (%)
- Comparison by Indication
  - Table Chart on Comparison by Indication
  - Table Data Table on Comparison by Indication
- Cervical cancer - Market size and forecast 2022-2027
  - Table Chart on Cervical cancer - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Cervical cancer - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Cervical cancer - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Cervical cancer - Year-over-year growth 2022-2027 (%)
- Anal cancer - Market size and forecast 2022-2027
  - Table Chart on Anal cancer - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Anal cancer - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Anal cancer - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Anal cancer - Year-over-year growth 2022-2027 (%)
- Vulvar and vaginal cancer - Market size and forecast 2022-2027
  - Table Chart on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Vulvar and vaginal cancer - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Vulvar and vaginal cancer - Year-over-year growth 2022-2027 (%)
- Others - Market size and forecast 2022-2027
  - Table Chart on Others - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Others - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Others - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Others - Year-over-year growth 2022-2027 (%)
- Market opportunity by Indication
  - Table Market opportunity by Indication ($ million)
  - Table Data Table on Market opportunity by Indication ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2022-2027 (%)
  - Table Data Table on Market share by geography 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2022-2027
  - Table Chart on North America - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on North America - Market size and forecast 2022-2027 ($ million)
  - Table Chart on North America - Year-over-year growth 2022-2027 (%)
  - Table Data Table on North America - Year-over-year growth 2022-2027 (%)
- Europe - Market size and forecast 2022-2027
  - Table Chart on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Europe - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Asia - Market size and forecast 2022-2027
  - Table Chart on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Asia - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Rest of World (ROW) - Market size and forecast 2022- 2027
  - Table Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- US - Market size and forecast 2022-2027
  - Table Chart on US - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on US - Market size and forecast 2022-2027 ($ million)
  - Table Chart on US - Year-over-year growth 2022-2027 (%)
  - Table Data Table on US - Year-over-year growth 2022-2027 (%)
- Germany - Market size and forecast 2022-2027
  - Table Chart on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Germany - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Germany - Year-over-year growth 2022-2027 (%)
- Canada - Market size and forecast 2022-2027
  - Table Chart on Canada - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Canada - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Canada - Year-over-year growth 2022-2027 (%)
- China - Market size and forecast 2022-2027
  - Table Chart on China - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on China - Market size and forecast 2022-2027 ($ million)
  - Table Chart on China - Year-over-year growth 2022-2027 (%)
  - Table Data Table on China - Year-over-year growth 2022-2027 (%)
- Brazil - Market size and forecast 2022-2027
  - Table Chart on Brazil - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Brazil - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Brazil - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Brazil - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
  - Table Data Tables on Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Advent of vaccines
  - Development of oral vaccines for HPV
  - Strong disease progression
- Market challenges
  - Anti-vaxxer movement
  - Multiple-dose schedules of vaccines
  - Lack of curative therapies
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - R and D of new drugs for Orthostatic Hypotension treatment
  - Use of combination therapy in OH treatment
  - Adoption of fludrocortisone as off label first line pharmacotherapy
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- 2A Pharma ApS
  - Table 2A Pharma ApS - Overview
  - Table 2A Pharma ApS - Product / Service
  - Table 2A Pharma ApS - Key offerings
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key news
  - Table AbbVie Inc. - Key offerings
- Bausch Health Co. Inc.
  - Table Bausch Health Co. Inc. - Overview
  - Table Bausch Health Co. Inc. - Business segments
  - Table Bausch Health Co. Inc. - Key news
  - Table Bausch Health Co. Inc. - Key offerings
  - Table Bausch Health Co. Inc. - Segment focus
- Bavarian Nordic AS
  - Table Bavarian Nordic AS - Overview
  - Table Bavarian Nordic AS - Product / Service
  - Table Bavarian Nordic AS - Key offerings
- BioVaxys Technology Corp.
  - Table BioVaxys Technology Corp. - Overview
  - Table BioVaxys Technology Corp. - Product / Service
  - Table BioVaxys Technology Corp. - Key offerings
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- GlaxoSmithKline Plc
  - Table GlaxoSmithKline Plc - Overview
  - Table GlaxoSmithKline Plc - Business segments
  - Table GlaxoSmithKline Plc - Key offerings
  - Table GlaxoSmithKline Plc - Segment focus
- Inovio Pharmaceuticals Inc.
  - Table Inovio Pharmaceuticals Inc. - Overview
  - Table Inovio Pharmaceuticals Inc. - Product / Service
  - Table Inovio Pharmaceuticals Inc. - Key news
  - Table Inovio Pharmaceuticals Inc. - Key offerings
- ISA Pharmaceuticals BV
  - Table ISA Pharmaceuticals BV - Overview
  - Table ISA Pharmaceuticals BV - Product / Service
  - Table ISA Pharmaceuticals BV - Key offerings
- Merck and Co. Inc.
  - Table Merck and Co. Inc. - Overview
  - Table Merck and Co. Inc. - Business segments
  - Table Merck and Co. Inc. - Key news
  - Table Merck and Co. Inc. - Key offerings
  - Table Merck and Co. Inc. - Segment focus
- Serum Institute of India Pvt. Ltd.
  - Table Serum Institute of India Pvt. Ltd. - Overview
  - Table Serum Institute of India Pvt. Ltd. - Product / Service
  - Table Serum Institute of India Pvt. Ltd. - Key offerings
- Walvax Biotechnology Co. Ltd.
  - Table Walvax Biotechnology Co. Ltd. - Overview
  - Table Walvax Biotechnology Co. Ltd. - Product / Service
  - Table Walvax Biotechnology Co. Ltd. - Key offerings
- Xiamen Innovax Biotech Co. Ltd.
  - Table Xiamen Innovax Biotech Co. Ltd. - Overview
  - Table Xiamen Innovax Biotech Co. Ltd. - Product / Service
  - Table Xiamen Innovax Biotech Co. Ltd. - Key offerings
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations